… of direct non-vitamin K oral anticoagulants versus vitamin K antagonists for the management of patients with non-valvular atrial fibrillation based on available “real …
V Lorenzoni, S Pirri, G Turchetti - Clinical drug investigation, 2021 - Springer
… (ie, rivaroxaban, dabigatran and apixaban) versus VKAs from … the risk of mortality, bleeding
and stroke for apixaban versus … in the analysis, representing first-line treatment with warfarin, …
and stroke for apixaban versus … in the analysis, representing first-line treatment with warfarin, …
Efficacy and safety of apixaban vs. warfarin in atrial fibrillation patients: Systematical review and meta-analysis
MFR Syaban, KC Yunita, IFD Faratisha… - Heart Science …, 2022 - heartscience.ub.ac.id
… and warfarin in non-valvular atrial fibrillation (NVAF) patients, … dose and a low dose of
apixaban to prevent ischemic stroke/… dabigatran and rivaroxaban, apixaban showed a significant …
apixaban to prevent ischemic stroke/… dabigatran and rivaroxaban, apixaban showed a significant …
Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation: a PRISMA-compliant article
SM Kim, ET Jeon, JM Jung, JS Lee - Medicine, 2021 - journals.lww.com
… Apixaban, dabigatran, and rivaroxaban had a lower risk of SSE than warfarin. The NOACs …
In addition, only low-dose dabigatran and rivaroxaban reduced the risk of IS, in contrast to the …
In addition, only low-dose dabigatran and rivaroxaban reduced the risk of IS, in contrast to the …
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk
TF Chao, YH Chan, CE Chiang, TC Tuan… - … Journal-Quality of …, 2022 - academic.oup.com
… The Edoxaban Low-Dose for EldeR CARE AF patients (… that in very elderly Japanese patients
with non-valvular AF who were … other DOACs (dabigatran, rivaroxaban, and apixaban) with …
with non-valvular AF who were … other DOACs (dabigatran, rivaroxaban, and apixaban) with …
Anti-factor Xa activity of standard and Japan-specific doses of rivaroxaban in Thai patients with non-valvular atrial fibrillation
W Wongcharoen, P Pacharasupa… - Circulation …, 2020 - jstage.jst.go.jp
… for the management of patients with atrial fibrillation: Executive sum… Bleeding risk of apixaban,
dabigatran, and low-dose rivar… with warfarin in Japanese patients with nonvalvular atrial …
dabigatran, and low-dose rivar… with warfarin in Japanese patients with nonvalvular atrial …
[HTML][HTML] … and safety of extended treatment with direct oral anticoagulants for venous thromboembolism in Japan: A retrospective cohort study using claims data
H Hashimoto, S Imai, A Kiyomi, M Sugiura - Thrombosis Update, 2022 - Elsevier
… record of DOACs (apixaban, rivaroxaban, or edoxaban) at least … Bleeding risk of apixaban,
dabigatran, and low-dose … with non-valvular atrial fibrillation: a propensity matched analysis …
dabigatran, and low-dose … with non-valvular atrial fibrillation: a propensity matched analysis …
[HTML][HTML] Real-world comparisons of low-dose Noacs versus standard-dose Noacs or warfarin on efficacy and safety in patients with AF: A meta-analysis
Z Li, X Wang, D Li, A Wen - Cardiology Research and Practice, 2022 - hindawi.com
… warfarin were defined as dabigatran 150mgb.id, rivaroxaban … Salgado, “Risk of bleeding
with 2 doses of dabigatran … Xa inhibitor apixaban in Japanese patients with non-valvular atrial …
with 2 doses of dabigatran … Xa inhibitor apixaban in Japanese patients with non-valvular atrial …
Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
S Srikajornlarp, M Amnueypol… - Clinical and Applied …, 2022 - journals.sagepub.com
… between AF patient groups receiving warfarin, dabigatran, rivaroxaban, and … the study on
Japanese administrative claims data 17 that apixaban harbored the lowest risk of any bleeding. …
Japanese administrative claims data 17 that apixaban harbored the lowest risk of any bleeding. …
Starting dose and dose adjustment of non-vitamin K antagonist oral anticoagulation agents in a nationwide cohort of patients with atrial fibrillation
L Gozzo, A Di Lenarda, F Mammarella, PP Olimpieri… - Scientific Reports, 2021 - nature.com
… overtime for dabigatran and rivaroxaban; whereas prescription of low dose apixaban and
edoxaban … Compared with warfarin, low dose apixaban was associated with a 37% lower …
edoxaban … Compared with warfarin, low dose apixaban was associated with a 37% lower …
[HTML][HTML] Dabigatran for Japanese patients with atrial fibrillation and prior stroke: a subgroup analysis of the J-Dabigatran Surveillance program
…, J-Dabigatran Surveillance Investigators - Journal of Stroke and …, 2020 - Elsevier
… risk of all-cause mortality and major bleeding including intracranial bleeding compared with
warfarin… /TIA, but not major bleeding, and commencement of rivaroxaban more than or equal …
warfarin… /TIA, but not major bleeding, and commencement of rivaroxaban more than or equal …